Although technological advance and product innovation are rapid today, manufacturers
of pharmaceutical capsules are often faced with particularly difficult challenges
when it comes to regulatory affairs. These tend to vary from region to region and
present problems regarding interpretation and the implementation of operational
procedures. They often leave important questions unanswered and lead to uncertainty.
The gelatine capsule industry in particular is subject to new and changing regulations
regarding pharmaceuticals and foodstuffs. These have to be understood and then
implemented. As the leading worldwide manufacturer of gelatine, GELITA is in regular
contact with the American, European and Asian-Pacific authorities. In this way, the
company is able to obtain information on planned regulatory changes and inform and
advise its customers correspondingly.
GELITA experts will gladly provide information on regulatory affairs, product
development, manufacture and marketing. In addition, GELITA customers are regularly
informed of new
|
developments in the Regulatory Affairs Newsletter published by the
company.
For more information, contact
service@gelita.com
|
